04/03/2024
3:51 PM | Harvard Bioscience (Filer)
| Form ARS | |
04/03/2024
7:01 AM | Harvard Bioscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/26/2024
4:00 PM | Harvard Bioscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/19/2024
12:02 PM | Harvard Bioscience (Subject)
Leviticus Partners LP (Filed by)
| Form SC 13G | |
03/07/2024
6:00 AM | Harvard Bioscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
7:46 AM | B. Riley Asset Management, LLC (Filed by)
Harvard Bioscience (Subject)
| Form SC 13G/A | |
01/26/2024
4:26 PM | BlackRock Inc. (Filed by)
Harvard Bioscience (Subject)
| Form SC 13G | |
01/22/2024
9:55 AM | Harvard Bioscience (Subject)
Leviticus Partners LP (Filed by)
| Form SC 13G/A | |
01/05/2024
4:01 PM | Harvard Bioscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/03/2024
4:17 PM | Cote Jennifer (Reporting)
Harvard Bioscience (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
4:18 PM | Green James W (Reporting)
Harvard Bioscience (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2023
3:45 PM | Harvard Bioscience (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2023
6:00 AM | Harvard Bioscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/28/2023
2:07 PM | Harvard Bioscience (Subject)
Leviticus Partners LP (Filed by)
| Form SC 13G | |
08/08/2023
8:05 AM | Harvard Bioscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/20/2023
7:15 AM | Harvard Bioscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/13/2023
3:02 PM | Green James W (Reporting)
Harvard Bioscience (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2023
3:17 PM | Harvard Bioscience (Filer)
| Form SD
Specialized Disclosure Report | |
05/23/2023
3:03 PM | Harvard Bioscience (Issuer)
LOY BERTRAND (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2023
3:04 PM | Harvard Bioscience (Issuer)
Loewald Thomas W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2023
3:07 PM | Eade Katherine A. (Reporting)
Harvard Bioscience (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
